Authors: PAIRET M VANRYN J SCHIEROK H MAUZ A TRUMMLITZ G ENGELHARDT G

Citation: M. Pairet et al., DIFFERENTIAL INHIBITION OF CYCLOOXYGENASES-1 AND CYCLOOXYGENASES-2 BYMELOXICAM AND ITS 4'-ISOMER, Inflammation research, 47(6), 1998, pp. 270-276

Authors: LAZER ES MIAO CK CYWIN CL SORCEK R WONG HC MENG ZX POTOCKI I HOERMANN M SNOW RJ TSCHANTZ MA KELLY TA MCNEILL DW COUTTS SJ CHURCHILL L GRAHAM AG DAVID E GROB PM ENGEL W MEIER H TRUMMLITZ G

Citation: Es. Lazer et al., EFFECT OF STRUCTURAL MODIFICATION OF ENOL-CARBOXAMIDE-TYPE NONSTEROIDAL ANTIINFLAMMATORY DRUGS ON COX-2 COX-1 SELECTIVITY/, Journal of medicinal chemistry, 40(6), 1997, pp. 980-989

Authors: LUGER P DANECK K ENGEL W TRUMMLITZ G WAGNER K

Citation: P. Luger et al., STRUCTURE AND PHYSICOCHEMICAL PROPERTIES OF MELOXICAM, A NEW NSAID, European journal of pharmaceutical sciences, 4(3), 1996, pp. 175-187

Authors: SCHMID J BUSCH U TRUMMLITZ G PROX A KASCHKE S WACHSMUTH H

Citation: J. Schmid et al., MELOXICAM - METABOLIC PROFILE AND BIOTRANSFORMATION PRODUCTS IN THE RAT, Xenobiotica, 25(11), 1995, pp. 1219-1236